Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 5:7:187-94.
doi: 10.1016/j.nicl.2014.12.004. eCollection 2015.

Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia

Affiliations

Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia

Chiara Cerami et al. Neuroimage Clin. .

Abstract

[(18)F]FDG-PET imaging has been recognized as a crucial diagnostic marker in Mild Cognitive Impairment (MCI), supporting the presence or the exclusion of Alzheimer's Disease (AD) pathology. A clinical heterogeneity, however, underlies MCI definition. In this study, we aimed to evaluate the predictive role of single-subject voxel-based maps of [(18)F]FDG distribution generated through statistical parametric mapping (SPM) in the progression to different dementia subtypes in a sample of 45 MCI. Their scans were compared to a large normal reference dataset developed and validated for comparison at single-subject level. Additionally, Aβ42 and Tau CSF values were available in 34 MCI subjects. Clinical follow-up (mean 28.5 ± 7.8 months) assessed subsequent progression to AD or non-AD dementias. The SPM analysis showed: 1) normal brain metabolism in 14 MCI cases, none of them progressing to dementia; 2) the typical temporo-parietal pattern suggestive for prodromal AD in 15 cases, 11 of them progressing to AD; 3) brain hypometabolism suggestive of frontotemporal lobar degeneration (FTLD) subtypes in 7 and dementia with Lewy bodies (DLB) in 2 subjects (all fulfilled FTLD or DLB clinical criteria at follow-up); and 4) 7 MCI cases showed a selective unilateral or bilateral temporo-medial hypometabolism without the typical AD pattern, and they all remained stable. In our sample, objective voxel-based analysis of [(18)F]FDG-PET scans showed high predictive prognostic value, by identifying either normal brain metabolism or hypometabolic patterns suggestive of different underlying pathologies, as confirmed by progression at follow-up. These data support the potential usefulness of this SPM [(18)F]FDG PET analysis in the early dementia diagnosis and for improving subject selection in clinical trials based on MCI definition.

Keywords: Alzheimer's disease; Dementia diagnosis; Mild Cognitive Impairment; PET imaging; [18F]FDG.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The SPM-t maps of hypometabolism of eight MCI cases, as example: PET patterns corresponding to Alzheimer's disease (A, B), behavioral variant of frontotemporal dementia (C, D), semantic variant of primary progressive aphasia (E), corticobasal degeneration (F), dementia with Lewy bodies (G, H). Yellow/red scales shown in SPM maps are regions which are hypometabolic in MCI patient in comparison to the normal control database (see text for details).
Fig. 2
Fig. 2
The SPM-t map of hypometabolism of an amnestic single domain MCI with mTLD-pattern displayed on axial view of an MRI standardized structural scan showing a selective temporo-mesial hypometabolic pattern (A). Axial T1-weighted MRI images showing mild-moderate selective temporo-mesial atrophy more pronounced on the left side (B). L = left; R = right.

References

    1. Alberici A., Geroldi C., Cotelli M., Adorni A., Calabria M., Rossi G. The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease. Neurol. Sci. 2007;28(2):80–86. 17464470 - PubMed
    1. Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270–279. 21514249 - PMC - PubMed
    1. Anchisi D., Borroni B., Franceschi M., Kerrouche N., Kalbe E., Beuthien-Beumann B. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch. Neurol. 2005;62(11):1728–1733. 16286547 - PubMed
    1. Armstrong M.J., Litvan I., Lang A.E., Bak T.H., Bhatia K.P., Borroni B. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80(5):496–503. 23359374 - PMC - PubMed
    1. Bateman R.J., Xiong C., Benzinger T.L., Fagan A.M., Goate A., Fox N.C. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 2012;367(9):795–804. 22784036 - PMC - PubMed

Publication types

Substances